Caleco acquires part of Natac Biotech
This article was originally published in The Tan Sheet
Executive Summary
Caleco Pharma plans to develop its supplement and drug pipeline with an agreement to acquire 18 percent of Natac Biotech - a Madrid firm that derives functional foods and active ingredients from natural substances, according to a Feb. 16 release. The agreement focuses on advanced research techniques in plant ingredient isolation and extraction and probiotic science, according to Bellingham, Wash.-based Caleco